Aripiprazole two-month long-acting injectable may increase time to readmission compared to aripiprazole one-month in patients with schizophrenia and schizoaffective disorder
{{output}}
Objective: Schizophrenia and schizoaffective disorder are primarily treated with antipsychotic medications, including long-acting injectables (LAIs) which help reduce relapse/readmission. New LAIs have longer duration of action, ... ...
